Abstract
Hyperhomocysteinemia (HHcy) has been considered a risk factor for different diseases, including cardiovascular disease (CVD), inflammation, neurological diseases, cancer, and many other pathological conditions. Likewise, arachidonic acid (AA) metabolism is implicated in both vascular homeostasis and inflammation, as shown by the development of CVD, following the imbalance of its metabolites. This review summarizes how homocysteine (Hcy) can influence the metabolism of AA. In silico literature searches were performed on PubMed and Scopus as main sources. Several studies have shown that altered levels of Hcy, through AA release and metabolism, can influence the synthesis and the activity of prostaglandins (PGs), prostacyclin (PGI2), thromboxane (TXA), epoxyeicosatrienoic acids (EETs), and hydroxyeicosatetraenoic acids (HETEs). It is believed that by targeting Hcy in the AA pathways, novel compounds with better pharmacological and pharmacodynamics benefits may be obtained and that this information is valuable for a dietician to manipulate diets to improve health.
Keywords: Homocysteine, hyperhomocysteinemia, arachidonic acid, cardiovascular diseases, epoxyeicosatrienoic acids, homeostasis.
Endocrine, Metabolic & Immune Disorders - Drug Targets
Title:The Interaction between Arachidonic Acid Metabolism and Homocysteine
Volume: 21 Issue: 7
Author(s): Elisa Domi, Malvina Hoxha*, Bianka Hoxha and Bruno Zappacosta
Affiliation:
- Department of Chemical-Toxicological and Pharmacological Evaluation of Drugs, Faculty of Pharmacy, Catholic University Our Lady of Good Counsel, Rruga Dritan Hoxha, Tirana,Albania
Keywords: Homocysteine, hyperhomocysteinemia, arachidonic acid, cardiovascular diseases, epoxyeicosatrienoic acids, homeostasis.
Abstract: Hyperhomocysteinemia (HHcy) has been considered a risk factor for different diseases, including cardiovascular disease (CVD), inflammation, neurological diseases, cancer, and many other pathological conditions. Likewise, arachidonic acid (AA) metabolism is implicated in both vascular homeostasis and inflammation, as shown by the development of CVD, following the imbalance of its metabolites. This review summarizes how homocysteine (Hcy) can influence the metabolism of AA. In silico literature searches were performed on PubMed and Scopus as main sources. Several studies have shown that altered levels of Hcy, through AA release and metabolism, can influence the synthesis and the activity of prostaglandins (PGs), prostacyclin (PGI2), thromboxane (TXA), epoxyeicosatrienoic acids (EETs), and hydroxyeicosatetraenoic acids (HETEs). It is believed that by targeting Hcy in the AA pathways, novel compounds with better pharmacological and pharmacodynamics benefits may be obtained and that this information is valuable for a dietician to manipulate diets to improve health.
Export Options
About this article
Cite this article as:
Domi Elisa , Hoxha Malvina *, Hoxha Bianka and Zappacosta Bruno , The Interaction between Arachidonic Acid Metabolism and Homocysteine, Endocrine, Metabolic & Immune Disorders - Drug Targets 2021; 21 (7) . https://dx.doi.org/10.2174/1871530320999200904130504
DOI https://dx.doi.org/10.2174/1871530320999200904130504 |
Print ISSN 1871-5303 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3873 |
Call for Papers in Thematic Issues
Advances in Therapeutic Strategies: Bridging Endocrine, Metabolic, Cancer and Immune Disorders for Precision Medicine.
The intricate interplay between endocrine, metabolic, and immunological disorders, addressing the challenges posed by their overlapping pathophysiology. With a focus on diseases such as diabetes, obesity, autoimmune thyroid conditions, and systemic inflammatory disorders, it highlights the transformative potential of precision medicine. Advances in genomics, transcriptomics, proteomics, and metabolomics are uncovering ...read more
Advancing Therapies for Bone and Joint Diseases: Insights from Natural Products and Herbal Medicines
The aging global population is experiencing an increased risk of bone and joint health issues, notably osteoporosis and osteoarthritis, affecting over half of individuals over 60. Plant-based natural products and herbal medicines are gaining recognition as alternative therapies for these conditions, with secondary metabolites, including flavonoids, coumarins, and others, playing ...read more
Association between Diabetes Mellitus and natural product complementary applications: State of the arts
Diabetes Mellitus (DM) represents a significant global health challenge, characterized by chronic hyperglycemia resulting from defects in insulin secretion, insulin action, or both. The increasing prevalence of DM, alongside its associated complications, has prompted researchers and healthcare professionals to explore a variety of management strategies beyond conventional pharmacotherapy. Among these ...read more
Chronic inflammation and Disorders/Cancers
Chronic inflammation is fundamental cause of variety of disorders. Many lifestyle-related diseases including metabolic syndrome, obesity, impairment of immune responses, sepsis, mental illness, and other disorders are caused by chronic inflammation. Prevention of chronic inflammation is related to antiaging effects of our body. Proinflammatory cytokines such as TNF-α is associated ...read more

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
From Discovery to Clinical Trials: Treatment Strategies for Central Neuropathic Pain after Spinal Cord Injury
Current Pharmaceutical Design Processed Foods, Dysbiosis, Systemic Inflammation, and Poor Health
Current Nutrition & Food Science Extra Virgin Olive Oils Polyphenols: Biological Activities
Current Pharmaceutical Design Antioxidant Effect of Flavonoids Present in Euterpe oleracea Martius and Neurodegenerative Diseases: A Literature Review
Central Nervous System Agents in Medicinal Chemistry Antiplatelet Therapy in Atherothrombotic Cardiovascular Diseases for Primary and Secondary Prevention: A Focus on Old and New Antiplatelet Agents
Current Pharmaceutical Design Heterologous Production of Peptides in Plants: Fusion Proteins and Beyond
Current Protein & Peptide Science Meet Our Editorial Board Member
Current Drug Research Reviews Molecular Docking and Dynamics Simulation Study on the Influence of Zn<sup>2+</sup> on the Binding Modes of Aggrecanase with its Inhibitors
Combinatorial Chemistry & High Throughput Screening Development and Biocompatibility Analysis of NBD Peptide Sustained- Release Microsphere Scaffold Nanoparticle SP-Sr-CaS/NBD
Current Drug Delivery Analysis of the Potential for HIV-1 Vpr as an Anti-Cancer Agent
Current HIV Research Endothelial Function: A Surrogate Endpoint in Cardiovascular Studies?
Current Pharmaceutical Design A Healthy Gut for a Healthy Brain: Preclinical, Clinical and Regulatory Aspects
Current Neuropharmacology New Therapeutic Applications of Phosphodiesterase 5 Inhibitors (PDE5-Is)
Current Medicinal Chemistry Leptin: The Prototypic Adipocytokine and its Role in NAFLD
Current Pharmaceutical Design Efficacy of Cannabis and its Constituents in Disease Management: Insights from Clinical Studies
Current Medicinal Chemistry The Effect of Nanocurcumin in Improvement of Knee Osteoarthritis: A Randomized Clinical Trial
Current Rheumatology Reviews Potential of Recombinant SV40-Based Vectors for Gene Therapy
Recent Patents on DNA & Gene Sequences Neutrophil Elastase as a Target in Lung Cancer
Anti-Cancer Agents in Medicinal Chemistry In Silico Drug Discovery Approaches on Grid Computing Infrastructures
Current Clinical Pharmacology Cancer Therapy: Targeting Mitochondria and other Sub-cellular Organelles
Current Pharmaceutical Design